글로벌 단일유전적 질환 치료 시장 - 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 글로벌 단일유전적 질병 치료 시장

글로벌 단일유전자성 질환 치료 시장은 2021년에서 2028년의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 위에서 언급한 예측 기간 동안 5%의 CAGR로 성장할 것으로 예상되는 시장을 분석합니다. 단일유전자성 질환 치료 시장에 대한 Data Bridge Market Research 보고서는 예측 기간 동안 만연할 것으로 예상되는 다양한 요인에 대한 분석과 통찰력을 제공하는 동시에 시장 성장에 미치는 영향을 제공합니다.

단일유전자성 질환은 한 유전자의 DNA 서열의 돌연변이 또는 변화 의 결과입니다 . 그 구성에 존재하는 단백질의 정상적인 기능은 돌연변이 유전자에 의해 방해를 받고 나중에 낭포성 섬유증, 겸상 적혈구 질환, 고셰병, SCID 등과 같은 다양한 유형의 단일유전자성 질환을 초래합니다.

단일유전자성 질환의 발생률 증가, 치료 기술의 발전, 유전적 질환에 대한 인식 제고, 신약 개발의 진전, 의료 인프라의 증가는 글로벌 단일유전자성 질환 치료 시장 성장을 견인하는 요인입니다.

2021~2028년 예측 기간 동안 연구개발 활동과 임상 시험의 증가, 치료법의 발전으로 글로벌 단일유전자 질환 치료 시장에 유익한 기회가 제공될 것으로 예상됩니다.

그러나 단일유전자성 질환 치료와 관련된 높은 비용과 예를 들어 유전자 치료의 낮은 치료 성공률은 제약으로 작용할 수 있으며, 치료에 대한 새로운 연구와 더불어 부작용의 증가는 위에 언급한 예측 기간 동안 글로벌 단일유전자성 질환 치료 시장에 더욱 큰 어려움을 줄 것입니다.

This monogenetic disease therapy market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global monogenetic disease therapy market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Monogenetic Disease Therapy Market Scope and Market Size

The monogenetic disease therapy market is segmented on the basis of inheritance pattern, therapy type, application, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of inheritance pattern, the global monogenetic disease therapy market is segmented into autosomal and chromosomal.
• On the basis of therapy type, the global monogenetic disease therapy market is segmented into pharmacological, surgical, blood transfusion, EBRT, gene therapies and others.
• On the basis of application, the global monogenetic disease therapy market is segmented into cystic fibrosis, SCID, sickle cell anemia, phenylketonuria and others.
• On the basis of end-users, the global monogenetic disease therapy market is segmented into clinics, hospitals, diagnostic centres, home healthcare and others.

The global monogenetic disease therapy market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Global Monogenetic Disease Therapy Market Country Level Analysis

Global monogenetic disease therapy market is analyzed and market size information is provided by the country, inheritance pattern, therapy type, application, end-users and distribution channel as referenced above.

The countries covered in the global monogenetic disease therapy market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the monogenetic disease therapy market due to the existence of huge number of players and increasing clinical trials in the region, well-developed healthcare sector and increase in the government support for research & development in this region. Global monogenetic disease therapy market in Europe and the Asia-Pacific is expected to grow during the forecast period, due to the increased occurrence of monogenetic diseases, combined with rising people’s healthcare expenditure.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Global monogenetic disease therapy market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to monogenetic disease therapy market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the monogenetic disease therapy market in the growth period.

Competitive Landscape and Global Monogenetic Disease Therapy Market Share Analysis

Global monogenetic disease therapy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to global monogenetic disease therapy market.

The major players covered in the global monogenetic disease therapy market are Abbott Laboratories, BAG Healthcare Gmbh, Novartis AG, Pfizer Inc., Vertex Pharmaceuticals, Bristol-Myers Squibb, F. Hoffmann-La Roche Limited, Bayer AG, Grifols S.A., Bluebird Bio, UniQure and Sanofi S.A. among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

SKU-63526